Quoin Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Quoin Pharmaceuticals Ltd
QNRX Stock  USD 0.30  0.01  3.23%   
Quoin Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Quoin Pharmaceuticals Ltd investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Quoin Pharmaceuticals financial statements helps investors assess Quoin Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Quoin Pharmaceuticals' valuation are summarized below:
Market Capitalization
2.5 M
Earnings Share
(3.66)
We have found one hundred twenty available trending fundamental ratios for Quoin Pharmaceuticals, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Quoin Pharmaceuticals recent market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 2.9 M in 2025. Enterprise Value is likely to rise to about (3.4 B) in 2025
Check Quoin Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quoin Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 6.2 B, Total Revenue of 0.0 or Other Operating Expenses of 7 M, as well as many indicators such as Dividend Yield of 7.58, Ptb Ratio of 3.0E-4 or Book Value Per Share of 1.6 K. Quoin financial statements analysis is a perfect complement when working with Quoin Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Quoin Pharmaceuticals Correlation against competitors.

Quoin Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets16.5 B15.7 B2 B
Slightly volatile
Property Plant And Equipment Net1.3 M2.2 M1.1 M
Slightly volatile
Cash3.8 B3.6 B467.4 M
Slightly volatile
Non Current Assets Total822.5 M783.3 M101 M
Slightly volatile
Cash And Short Term Investments3.8 B3.6 B468.5 M
Slightly volatile
Common Stock Shares Outstanding4.5 M4.7 M50.2 B
Slightly volatile
Liabilities And Stockholders Equity16.5 B15.7 B2 B
Slightly volatile
Other Stockholder Equity67.6 B64.4 B8.3 B
Slightly volatile
Total Current Assets15.7 B14.9 B1.9 B
Slightly volatile
Short and Long Term Debt Total3 K3.2 K46.8 M
Pretty Stable
Total Current Liabilities4.4 B4.2 B537.8 M
Slightly volatile
Net Receivables61.8 K69.6 K75.9 K
Slightly volatile
Non Current Liabilities Total1.7 B2.3 B693.1 M
Slightly volatile
Inventory0.80.90.9813
Slightly volatile
Other Current Assets11.9 B11.3 B1.4 B
Slightly volatile
Total Liabilities6.8 B6.5 B836.5 M
Slightly volatile
Short Term Debt51354046.6 M
Pretty Stable
Intangible Assets507.5 M483.3 M62.8 M
Slightly volatile
Short and Long Term Debt970.6 K1.1 M1.2 M
Slightly volatile
Other Liabilities298.9 K336.2 K366.6 K
Slightly volatile

Quoin Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative6.2 B5.9 B764.8 M
Slightly volatile
Other Operating Expenses7 M8.4 M11.5 M
Slightly volatile
Research Development3.8 B3.6 B466.6 M
Slightly volatile
Total Operating Expenses10 B9.5 B1.2 B
Slightly volatile
Depreciation And Amortization96.1 K119 K52.4 K
Slightly volatile
Cost Of Revenue102.9 K93.1 K180.2 K
Slightly volatile
Reconciled Depreciation96.1 K119.6 K52.4 K
Slightly volatile
Selling And Marketing Expenses4.9 B5.5 B6 B
Slightly volatile

Quoin Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation105 M100 M12.9 M
Slightly volatile
Begin Period Cash Flow2.5 B2.4 B308.6 M
Slightly volatile
Change To Account Receivables67.3 K54.2 K90.2 K
Slightly volatile
Total Cash From Financing Activities11.5 B11 B1.4 B
Slightly volatile
Change To Netincome973.5 K1 M1.4 M
Pretty Stable
Dividends Paid52.2 M58.7 M64 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield7.588.549.3054
Slightly volatile
Average Payables475.8 M453.1 M58.4 M
Slightly volatile
Capex To Depreciation2.612.163.5411
Slightly volatile
Days Of Inventory On Hand0.00340.00180.0029
Slightly volatile
Payables Turnover0.170.180.4887
Very volatile
Average Inventory0.40.450.4906
Slightly volatile
Cash Per Share7347731.9 K
Slightly volatile
Days Payables Outstanding1.4 K1.7 K2 K
Pretty Stable
Income Quality0.870.87670.7867
Very volatile
Intangibles To Total Assets0.02920.03080.1595
Pretty Stable
Current Ratio4.513.574.1706
Pretty Stable
Capex Per Share0.680.7151.4039
Slightly volatile
Average Receivables83.4 K44.4 K86.7 K
Slightly volatile
Interest Debt Per Share0.00330.00351.8 K
Pretty Stable
Debt To Assets2.0E-43.0E-45.0338
Pretty Stable
Graham Number25.2 K19.1 K24.7 K
Slightly volatile
Days Of Payables Outstanding1.4 K1.7 K2 K
Pretty Stable
Ebt Per Ebit1.111.061.0229
Slightly volatile
Long Term Debt To Capitalization0.690.780.8466
Slightly volatile
Quick Ratio4.513.574.1706
Pretty Stable
Net Income Per E B T0.650.90.8249
Pretty Stable
Cash Ratio0.820.86661.628
Pretty Stable
Operating Cash Flow Sales Ratio14.7821.1318.4021
Slightly volatile
Days Of Inventory Outstanding0.00340.00180.0029
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.850.931.0328
Slightly volatile
Debt Ratio2.0E-43.0E-45.0338
Pretty Stable
Gross Profit Margin1.11.31.3607
Very volatile

Quoin Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.9 M3.1 M13.8 M
Slightly volatile

Quoin Fundamental Market Drivers

Cash And Short Term Investments3.6 B

Quoin Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Quoin Pharmaceuticals Financial Statements

Quoin Pharmaceuticals investors use historical fundamental indicators, such as Quoin Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quoin Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue(690.00)(724.50)
Cost Of Revenue93.1 K102.9 K
Sales General And Administrative To Revenue(25.61)(26.89)
Research And Ddevelopement To Revenue(26.54)(27.86)
Capex To Revenue(0.59)(0.62)
Revenue Per Share(116.82)(122.66)
Ebit Per Revenue(49.23)(51.69)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY